Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 03 tags : Sciences save search
Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at ASN’s Kidney Week 2022 Annual Meeting
Published: 2022-11-03 (Crawled : 15:00) - biospace.com/
KZR | $0.81 -1.94% 310K
|
Health Technology
|
| O: -1.63%
H: 3.45%
C: -1.52%
sciences meeting lupus life kidney week trial positive results
Alpine Immune Sciences to Present ALPN-303 Phase 1 (RUBY-1) Study Data at 2022 American Society of Hematology Annual Meeting & Exposition
Published: 2022-11-03 (Crawled : 14:00) - biospace.com/
ALPN | $64.575 0.04% 920K
|
Health Technology
|
| O: -0.17%
H: 9.68%
C: 7.68%
alpn-303 sciences meeting study phase 1
Cassava Sciences Files Lawsuit Against Perpetrators of “Short and Distort” Campaign
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
SAVA M | $20.56 0.05% 280K
|
Health Technology
|
| O: 0.56%
H: 8.02%
C: -4.76%
sciences
SELLAS Life Sciences to Present Data on its Highly Selective CDK9 Inhibitor, GFH009, at the 2022 American Society of Hematology (ASH) Annual Meeting
Published: 2022-11-03 (Crawled : 14:00) - globenewswire.com
SLS | $1.55 -4.91% 1.1M
|
Health Technology
|
| O: -1.25%
H: 11.17%
C: 10.41%
gfh009 sciences meeting life
Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients
Published: 2022-11-03 (Crawled : 13:20) - biospace.com/
SGHT | $5.63 -0.18% 54K
|
|
| O: -0.65%
H: 4.86%
C: -1.71%
GKOS | $102.645 1.53% 260K
|
Health Technology
|
| O: -3.5%
H: 0.93%
C: -6.36%
omni glaucoma sciences system publication
Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
SGHT | $5.63 -0.18% 54K
|
|
| O: -0.65%
H: 4.86%
C: -1.71%
GKOS | $102.645 1.53% 260K
|
Health Technology
|
| O: -3.5%
H: 0.93%
C: -6.36%
omni glaucoma sciences system publication
Wave Life Sciences to Webcast Conference Call of Third Quarter 2022 Financial Results on November 10, 2022
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
WVE | $5.18 1.97% 250K
|
Health Technology
|
| O: -1.45%
H: 4.82%
C: 0.0%
sciences conference life financial results
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
RILY | $30.01 38.17% 11M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.